Emily P. Hyle, Adam D. Lipworth, Theoklis E. Zaoutis, Irving Nachamkin, Neil O. Fishman, Warren B. Bilker, Xiangquin Mao, Ebbing Lautenbach https://www.jstor.org ...

Extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) have become a critical global public health challenge due to their high resistance to β-lactam antibiotics and association with severe ...

In a recent study published in the Microbiology Spectrum Journal, researchers suggest that Escherichia coli ST2797 could potentially be a new type of extended-spectrum beta-lactamase (ESBL) ...

We describe the prevalence and molecular characteristics of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae causing nosocomial bacteremia and urinary tract infections in a Mexican ...

WALTHAM, Mass.--(BUSINESS WIRE)--Entasis Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced initiation ...

Individual risk assessment with automated EHR alerts are an effective and safe strategy to limit use of extended-spectrum antibiotics in patients hospitalized with UTI. An antibiotic stewardship ...

Purpose: Recently, we have noticed an increased incidence of infections caused by antibiotic-resistant pathogens including ESBL-producing microorganisms in our NICU patients. The purpose of this study ...

To date, our understanding of the epidemiology of KPC resistance is limited to outbreaks and infections reported from tertiary care academic medical centers. The epidemiology of KPC infections in the ...

Illustration of Enterobacteriaceae bacteria. Individual bacterium are shown as pink rod shapes. The Enterobacteriaceae family contains over a hundred species including Shigella, Klebsiella, Salmonella ...

Carbapenems have long been a reliable last line of defense in the treatment of infections caused by antimicrobial-resistant Enterobacteriaceae. The emergence of KPC resistance is a major threat to ...